Study compares sleep medicines for chronic pain insomnia
Treatments studied
Part of Brain & nervous system, Mental health, Pain clinical trials.
This trial tests different treatments to help people with long-term (chronic) pain and severe insomnia sleep better. It’s looking at three options—one medicine (lemborexant) compared with existing sleep medicines (zopiclone and clonidine)—and whether they improve sleep when non-medicine sleep strategies haven’t worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with chronic pain and severe ongoing insomnia
- You have tried non-medication sleep approaches but they did not help
- You have taken zopiclone regularly for at least 3 months
- You can keep a regular sleep diary and pain diary, and you agree to review it
- You do not have certain sleep, health, or safety issues (like sleep apnea) and avoid excluded substances/medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sleep improvement program to help people with chronic widespread pain reduce or stop their opioid pain medication. If you want to cut back on opioids and have trouble sleeping, this treatment might be a good fit.
This study looks at how the brain works in people with chronic low back pain and/or chronic insomnia. It compares these groups to healthy volunteers using MRI and pain tests.
This study tests whether adding a sleep specialist to your pain care team can help you feel better. If you have chronic pain (lasting over 3 months) and are now seeing a pain doctor for the first time, you may be able to join.
This trial compares two treatments for chronic insomnia: cognitive behavioral therapy (CBT-I) and a medication called lemborexant. It aims to find which works better for different types of insomnia. You may qualify if you have ongoing trouble sleeping and are not taking other sleep aids.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.